BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 1066997)

  • 1. The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study.
    Engel AG; Tsujihata M; Lindstrom JM; Lennon VA
    Ann N Y Acad Sci; 1976; 274():60-79. PubMed ID: 1066997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations.
    Engel AG; Tsujihata M; Lambert EH; Lindstrom JM; Lennon VA
    J Neuropathol Exp Neurol; 1976; 35(5):569-87. PubMed ID: 956872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis.
    Sahashi K; Engel AG; Linstrom JM; Lambert EH; Lennon VA
    J Neuropathol Exp Neurol; 1978; 37(2):212-23. PubMed ID: 147324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural study of neuromuscular junctions in experimental autoimmune myasthenia gravis (EAMG) in rabbits.
    Arizono N; Takeoka O; Hasegawa M; Yonezawa T; Yamaguchi K
    Acta Pathol Jpn; 1985 May; 35(3):621-9. PubMed ID: 4036600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor.
    Engel AG; Sakakibara H; Sahashi K; Lindstrom JM; Lambert EH; Lennon VA
    Neurology; 1979 Feb; 29(2):179-88. PubMed ID: 571062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.
    Engel AG; Lindstrom JM; Lambert EH; Lennon VA
    Neurology; 1977 Apr; 27(4):307-15. PubMed ID: 557772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis.
    Fumagalli G; Engel AG; Lindstrom J
    J Neuropathol Exp Neurol; 1982 Nov; 41(6):567-79. PubMed ID: 6982313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis.
    Sahashi K; Engel AG; Lambert EH; Howard FM
    J Neuropathol Exp Neurol; 1980 Mar; 39(2):160-72. PubMed ID: 7373347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological observations on motor end-plates in rabbits with experimental myasthenia.
    Thornell LE; Sjöström M; Mattsson CH; Heilbronn E
    J Neurol Sci; 1976 Oct; 29(2-4):389-410. PubMed ID: 978217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limb muscle endplates in ocular myasthenia gravis: quantitative ultrastructural study.
    Tsujihata M; Hazama R; Ishii N; Ide Y; Mori M; Takamori M
    Neurology; 1979 May; 29(5):654-61. PubMed ID: 571563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor.
    Gomez CM; Wollmann RL; Richman DP
    Acta Neuropathol; 1984; 63(2):131-43. PubMed ID: 6610275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural study of the motor end-plate in botulism and Lambert-Eaton myasthenic syndrome.
    Tsujihata M; Kinoshita I; Mori M; Mori K; Shirabe S; Satoh A; Nagataki S
    J Neurol Sci; 1987 Nov; 81(2-3):197-213. PubMed ID: 3694228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid treatment for experimental autoimmune myasthenia gravis.
    Barone DA; Lambert DH; Poser CM
    Arch Neurol; 1980 Oct; 37(10):663-6. PubMed ID: 7425891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular Transmission in experimental autoimmune myasthenia gravis (EAMG). Quantitative ionophoresis and current fluctuation analysis at normal and myasthenic rat end-plates.
    Hohlfeld R; Sterz R; Kalies I; Peper K; Wekerle H
    Pflugers Arch; 1981 May; 390(2):156-60. PubMed ID: 6264388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term administration of ambenonium chloride on motor end-plate fine structure and acetylcholine receptor in rat.
    Hazama R; Tsujihata M; Mori M; Takamori M; Mori K; Shibuya N
    J Neurol Sci; 1981 Jul; 51(1):69-79. PubMed ID: 7252521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis. Current concepts.
    Gutmann L; Chou SM
    Arch Pathol Lab Med; 1976 Aug; 100(8):401-4. PubMed ID: 947303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructure of motor endplates in canine congenital myasthenia gravis.
    Wilkes MK; McKerrell RE; Patterson RC; Palmer AC
    J Comp Pathol; 1987 May; 97(3):247-56. PubMed ID: 3611429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis.
    Kelly JJ; Lambert EH; Lennon VA
    Ann Neurol; 1978 Jul; 4(1):67-72. PubMed ID: 211931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular blocking properties of suxamethonium and decamethonium in normal and myasthenic rat muscle.
    Johnson BR; Kim YI; Sanders DB
    J Neurol Sci; 1983 Jun; 59(3):431-40. PubMed ID: 6875609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.